17: Ablin RJ. The need for personalized therapy and companion diagnostics in
prostate cancer. Biomark Med. 2011 Jun;5(3):281-3. doi: 10.2217/bmm.11.42. PubMed
PMID: 21657837.


18: Ablin RJ. A retrospective and prospective overview of prostate-specific
antigen. J Cancer Res Clin Oncol. 1997;123(11-12):583-94. Review. PubMed PMID:
9620215.


19: Ablin RJ, Gonder MJ. Immunological aspects of benign and malignant tumors of 
the prostate. Contrib Gynecol Obstet. 1985;14:185-98. Review. PubMed PMID:
2415296.


20: Ablin RJ. Immunomodulatory effects of oestrogen in prostatic cancer: update
and further consideration. Allergol Immunopathol (Madr). 1981 Jan-Feb;9(1):63-70.
PubMed PMID: 7258047.


21: Ablin RJ. Modulatory effects of estrogen on immunologic responsiveness. III. 
Effect of hormonal versus nonhormonal therapy on tumor-associated immunity in
prostatic cancer. Am J Reprod Immunol. 1981 Aug;1(4):206-9. PubMed PMID: 7337156.


22: Ablin RJ, Fontana G. Cryoimmunotherapy: continuing studies toward determining
a rational approach for assessing the candidacy of the prostatic cancer patient
for cryoimmunotherapy and postoperative responsiveness. An interim report.
Cryobiology. 1980 Apr;17(2):170-7. Review. PubMed PMID: 6995026.


23: Ablin RJ, Bhatti RA, Bush IM, Guinan PD. Suppression of tumor-associated
immunity by human seminal plasma and its possible role in the natural history of 
prostatic cancer. Eur Urol. 1980;6(4):225-8. PubMed PMID: 7389776.


24: Ablin RJ, Fontana G, Sesia G. [Immunological response to cryonecrosis of
prostatic carcinoma. Preliminary evaluation of patient candidates for
cryosurgery]. Minerva Urol. 1979 Oct-Dec;31(4):223-8. Italian. PubMed PMID:
542195.


25: Ablin RJ, Bhatti RA, Guinan PD, Bush IM. Effect of human seminal plasma on
tumour-associated immunity in prostatic cancer. A preliminary report.
Experientia. 1979 Nov 15;35(11):1510-11. PubMed PMID: 510506.


26: Ablin RJ, Fontana G. Cryoimmunotherapy: continuing studies toward determining
a rational approach for assessing the candidacy of the prostatic cancer patient
for cryoimmunotherapy and postoperative responsiveness. An interim report. Eur
Surg Res. 1979;11(4):223-33. PubMed PMID: 527611.


27: Ablin RJ, Bruns GR, Guinan PD, Al Sheik H, Bush IM. Modulatory effects of
oestrogen on immunologic responsiveness. I. Inhibition of DNA synthesis in
peripheral blood lymphocytes from patients with Peyronie's disease, prostatic
cancer and transsexuals and a commentary. Eur Urol. 1979;5(6):359-68. PubMed
PMID: 467472.


28: Ablin RJ, Bhatti RA, Guinan PD. Effect of estrogen on tumor-associated
immunity in patients with adenocarcinoma of the prostate. Cancer Res. 1978
Nov;38(11 Pt 1):3702-6. PubMed PMID: 698929.


29: Ablin RJ, Bruns GR, Guinan PD, Sadoughi N, Sheik HA, Bush IM. Alterations in 
host responsiveness in patients with prostatic cancer following cryosurgery or
transurethral resection. Am Surg. 1977 Mar;43(3):144-50. PubMed PMID: 320926.


30: Ablin RJ. Serum proteins in prostatic cancer VI. Reduction of the suppressive
("blocking"?) properties of serum on in vitro parameters of cell-mediated
immunologic responsiveness following cryosurgery. Urol Int. 1977;32(1):65-73.
PubMed PMID: 70099.


31: Ablin RJ. Possible suppression of host resistance by estrogen therapy for
prostatic cancer. Can Med Assoc J. 1976 Dec 4;115(11):1082-4. PubMed PMID:
1000436; PubMed Central PMCID: PMC1878895.


32: Ablin RJ, Guinan PD, Bruns GR, Sheik HI, Sadoughi N, Bush IM. Evaluation of
cellular immunologic responsiveness in the clinical management of patients with
prostatic cancer. II. Effect of oestrogen, cryosurgery and transurethral
resection on thymic-dependent lymphocytic blastogenesis. Urol Int.
1976;31(5):383-400. PubMed PMID: 1087494.


33: Ablin RJ. A rational approach toward determining the candidacy of the
prostatic cancer patient for cryoimmunotherapy: an interim report. Eur Surg Res. 
1976;8(6):481-4. PubMed PMID: 1017432.


34: Ablin RJ. Cryosensitivity. Factors influencing development of immunologic
response following cyrosurgery of prostate. Urology. 1975 Mar;05(3):317-21.
PubMed PMID: 1118992.


35: Ablin RJ. Immunotherapy for prostatic cancer. Previous and prospective
considerations. Oncology. 1975;31(3-4):177-202. Review. PubMed PMID: 1105280.


36: Ablin RJ, Burns GR, Guinan P, Bush IM. Antiandrogenic suppression of
lymphocytic blastogenesis: in vitro and in vivo observations. Experientia. 1974
Nov 15;30(11):1351-3. PubMed PMID: 4435189.


37: Ablin RJ. Interference of immunologic surveillance by immunoregulatory alpha 
globulin--a hypothesis. Neoplasma. 1973;20(2):159-62. PubMed PMID: 4122507.